Annual Total Liabilities
$260.60 K
-$808.20 K-75.62%
June 30, 2024
Summary
- As of February 8, 2025, ANEB annual total liabilities is $260.60 thousand, with the most recent change of -$808.20 thousand (-75.62%) on June 30, 2024.
- During the last 3 years, ANEB annual total liabilities has risen by +$19.00 thousand (+7.86%).
- ANEB annual total liabilities is now -91.86% below its all-time high of $3.20 million, reached on June 30, 2020.
Performance
ANEB Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$569.20 K
+$308.60 K+118.42%
September 30, 2024
Summary
- As of February 8, 2025, ANEB quarterly total liabilities is $569.20 thousand, with the most recent change of +$308.60 thousand (+118.42%) on September 30, 2024.
- Over the past year, ANEB quarterly total liabilities has dropped by -$441.10 thousand (-43.66%).
- ANEB quarterly total liabilities is now -95.85% below its all-time high of $13.73 million, reached on March 31, 2021.
Performance
ANEB Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
ANEB Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -75.6% | -43.7% |
| 3 y3 years | +7.9% | -43.7% |
| 5 y5 years | -91.9% | -43.7% |
ANEB Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -75.6% | +7.9% | -61.8% | +1040.7% |
| 5 y | 5-year | -91.9% | +7.9% | -95.8% | +1040.7% |
| alltime | all time | -91.9% | +7.9% | -95.8% | +1040.7% |
Anebulo Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $569.20 K(+118.4%) |
| Jun 2024 | $260.60 K(-75.6%) | $260.60 K(-74.2%) |
| Mar 2024 | - | $1.01 M(-0.3%) |
| Dec 2023 | - | $1.01 M(+41.4%) |
| Sep 2023 | - | $716.60 K(-33.0%) |
| Jun 2023 | $1.07 M | $1.07 M(-28.3%) |
| Mar 2023 | - | $1.49 M(+8.6%) |
| Dec 2022 | - | $1.37 M(+96.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $698.20 K(+36.2%) |
| Jun 2022 | $512.50 K(+112.1%) | $512.50 K(+497.3%) |
| Mar 2022 | - | $85.80 K(+71.9%) |
| Dec 2021 | - | $49.90 K(-91.8%) |
| Sep 2021 | - | $607.70 K(+151.5%) |
| Jun 2021 | $241.60 K(-92.4%) | $241.60 K(-98.2%) |
| Mar 2021 | - | $13.73 M(+312.3%) |
| Dec 2020 | - | $3.33 M |
| Jun 2020 | $3.20 M | - |
FAQ
- What is Anebulo Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Anebulo Pharmaceuticals?
- What is Anebulo Pharmaceuticals annual total liabilities year-on-year change?
- What is Anebulo Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Anebulo Pharmaceuticals?
- What is Anebulo Pharmaceuticals quarterly total liabilities year-on-year change?
What is Anebulo Pharmaceuticals annual total liabilities?
The current annual total liabilities of ANEB is $260.60 K
What is the all time high annual total liabilities for Anebulo Pharmaceuticals?
Anebulo Pharmaceuticals all-time high annual total liabilities is $3.20 M
What is Anebulo Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, ANEB annual total liabilities has changed by -$808.20 K (-75.62%)
What is Anebulo Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of ANEB is $569.20 K
What is the all time high quarterly total liabilities for Anebulo Pharmaceuticals?
Anebulo Pharmaceuticals all-time high quarterly total liabilities is $13.73 M
What is Anebulo Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, ANEB quarterly total liabilities has changed by -$441.10 K (-43.66%)